A detailed history of Apeiron Capital LTD transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Apeiron Capital LTD holds 7,500 shares of TMDX stock, worth $458,025. This represents 0.29% of its overall portfolio holdings.

Number of Shares
7,500
Holding current value
$458,025
% of portfolio
0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

BUY
$59.28 - $144.9 $444,600 - $1.09 Million
7,500 New
7,500 $467,000
Q2 2023

Jul 24, 2023

BUY
$66.23 - $88.73 $765,221 - $1.03 Million
11,554 New
11,554 $970,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.94B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Apeiron Capital LTD Portfolio

Follow Apeiron Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Capital LTD with notifications on news.